Weighing Risks Vs. Benefits of Systemic AD Treatments
By Denise Mann, MS Shared-decision making focused on weighing risks versus benefits is key when choosing the most appropriate systemic atopic dermatitis (AD) treatment for a patient, according to new research presented at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC. For the study, researchers reviewed the benefits […]